Molefy Pharma’s Research Places the Canary Islands at the Heart of the Fight Against ALS
The company collaborated with Molefy Pharma, the CSIC and the Government of the Canary Islands in an event that brought together experts to address the scientific, care-related and social challenges of Amyotrophic Lateral Sclerosis.